ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,296Medicare Part D Prescriptions Filled, Including Refills

Rank: 169 out of 1006

$607K Total Retail Price of All Prescriptions

Rank: 152 out of 1006

290 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 290 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

4% of this provider’s 290 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 7,733 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

33% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$73 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
LISINOPRIL 299 257 1 3
AMLODIPINE BESYLATE 286 274 2 4
ATORVASTATIN CALCIUM 278 255 3 5
FUROSEMIDE 256 252 4 6
SIMVASTATIN 256 235 4 1
WARFARIN SODIUM 209 189 6 8
METOPROLOL SUCCINATE 185 174 7 12
CRESTOR 178 143 8 18
PRAVASTATIN SODIUM 167 162 9 15
METFORMIN HCL 167 155 9 10
LEVOTHYROXINE SODIUM 163 163 11 2
METOPROLOL TARTRATE 142 139 12 7
BYSTOLIC 138 122 13 84
ZOLPIDEM TARTRATE 112 112 14 14
MIRTAZAPINE 106 96 15 26
ALENDRONATE SODIUM 99 99 16 29
SYNTHROID 97 86 17 42
ESCITALOPRAM OXALATE 96 85 18 27
CYMBALTA 96 96 18 41
CARVEDILOL 93 93 20 36
SERTRALINE HCL 90 85 21 19
OMEPRAZOLE 89 59 22 9
NEXIUM 80 79 23 28
ATELVIA 78 78 24 182
GABAPENTIN 77 76 25 20
ADVAIR DISKUS 77 74 25 37
CITALOPRAM HBR 77 75 25 24
LIPITOR 76 76 28 47
CLOPIDOGREL 75 75 29 46
TRAZODONE HCL 70 61 30 21
QUETIAPINE FUMARATE 69 55 31 45
BENICAR 68 68 32 78
NAMENDA 68 68 32 34
LISINOPRIL-HYDROCHLOROTHIAZIDE 68 68 32 38
DONEPEZIL HCL 64 64 35 17
RISPERIDONE 63 56 36 40
LEVETIRACETAM 62 51 37 72
AGGRENOX 62 48 37 203
AMLODIPINE BESYLATE-BENAZEPRIL 61 59 39 77
ETODOLAC 57 54 40 285
SPIRONOLACTONE 56 56 41 71
PAROXETINE HCL 55 55 42 62
HYDROCHLOROTHIAZIDE 52 49 43 11
DIOVAN 51 51 44 16
SEROQUEL 50 42 45 97
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.